IMPORTANT NOTICE TO CLASS MEMBERS

DEFICIENCY PERIOD HAS BEGUN

Updated: July 2, 2025

Attention Claimants,

The Deficiency Period for the OxyContin® and OxyNEO® Class Action Settlement has now begun.

If you submitted a claim and it was found to be incomplete or technical deficient, you will receive a deficiency notice by mail from the Claims Administrator shortly.

🔍 What This Means for You:

• The notice will outline the specific deficiencies in your claim and provide instructions on how to correct them.
• You have 90 days from the date of your deficiency notice to submit the required information or documentation or your claim may be rejected in part or in whole. 

✅ What To Do:

✔ Check your mail regularly for a deficiency notice from the Claims Administrator. If you have not received a deficiency notice by July 18, 2025, please contact the Claims Administrator by email or telephone. 

✔ Gather and provide the required documentation outlined on the deficiency letter, inlcuding:

• Medical and pharmacy records from the three years prior to your first OxyContin® or OxyNEO® prescription, through to the end of your Period of Addiction.
• If some or all records are unavailable, you may swear or affirm responses on the deficiency letter and return it.  If you require assistance with this, the Claims Administrator can swear or affirm your response remotely, free of charge.  Please contact us by phone or email for support.
• Mandatory evidence for Eligible Events.

✔ Respond promptly to the deficiency notice to avoid missing the 90-day deadline.

📞 For Assistance:

If you have questions and/or require the Claims Administrator to swear or affirm your deficiency response remotely, free of charge, contact the Claims Administrator:

• Phone: 1-888-663-7185
• Email: [email protected]
• Website: www.oxycontinclassactionsettlement.com

 

We strongly encourage all Class Members to act promptly and correct deficiencies within 90 days or your claim may be rejected in part or whole

Settlement Details

The Settlement Agreement was approved Canada-wide on November 8, 2022, and the approval became final on February 6, 2023. You and your family members may be entitled to compensation if you were prescribed in Canada, ingested, and subsequently developed an addiction to OxyContin® and/or OxyNEO® tablets at any time between January 1, 1996 and February 28, 2017.

Who is Eligible to Participate in the Settlement?

The Class Members are defined as:

All persons in Canada, including their estates, who at any time between January 1, 1996 and February 28, 2017 were prescribed in Canada and ingested OxyContin® tablets and/or OxyNEO® tablets, manufactured, marketed and/or sold or otherwise placed into the stream of commerce in Canada by one or more of the Defendants (the “Class” or “Class Members”); and

All persons in Canada who by virtue of a personal relationship to a Class Member have a Family Law Act, R.S.O. 1990, c.F.3 (or equivalent legislation in other provinces or territories) derivative claim (the “Family Class” or “Family Class Members”).

What does the Settlement Provide?

The Canada-wide Settlement provides for the payment of $20,000,000 (Canadian dollars) which will be used to pay Class Member compensation, the administration of the Settlement, health care expenses incurred by the Provincial Health Insurers, and Class Counsel’s legal fees, disbursements, and applicable taxes. The amount that will be paid to eligible Class Members will be unknown until after the end of the Claims Period, and after all administration has been completed.

For more information about how compensation is determined, you should review the Settlement Agreement, the proof requirements in FAQ 9 or contact the Claims Administrator (see Contact Us tab) or Class Counsel (see FAQ 18).

Check out the Frequently Asked Questions section for more details on the Settlement.

PLEASE DO NOT CONTACT PURDUE OR THE COURTS FOR INFORMATION.